Nfl gene inactivation in acute myeloid leukemia cells confers cytarabine resistance through MAPK and mTOR pathways. [electronic resource]
- Leukemia Jan 2006
- 151-4 p. digital
Publication Type: Letter; Research Support, Non-U.S. Gov't
0887-6924
10.1038/sj.leu.2404033 doi
Acute Disease Animals Cell Death--drug effects Cell Line, Tumor Cytarabine--pharmacology Drug Resistance, Neoplasm Humans Leukemia, Myeloid--drug therapy Mice Mitogen-Activated Protein Kinases--metabolism Neurofibromin 1--deficiency Protein Kinases--metabolism Signal Transduction--drug effects TOR Serine-Threonine Kinases